METHODS: Adult patients with advanced cancer who scored ≥4 in at least two or more symptoms based on the Edmonton Symptom Assessment Scale (ESAS) were recruited from January to March 2020 at the University of Malaya Medical Centre, Malaysia. Participants were randomly assigned to receive either four daily sessions of 30 min mindful breathing and standard care (intervention) or standard care alone (control). The outcome measured was the change in the ESAS score after each session.
RESULTS: 80 patients were recruited and randomised equally into the intervention and control groups. The demographic and clinical characteristics between the two groups were not statistically different. For the intervention group, there were statistically significant reductions in the total ESAS scores following all four sessions of 30 min mindful breathing (n1=40: z1=-5.09, p<0.001; z2=-3.77, p<0.001; z3=-4.38, p<0.001; z4=-3.27, p<0.05). For the control group, statistically significant reductions in the total ESAS scores were seen only after sessions 1 and 3 (n2=40: z1=-4.04, p<0.001; z3=-4.53, p<0.001).
CONCLUSIONS: Our result provides evidence that four daily sessions of 30 min mindful breathing may be effective in reducing multiple symptoms rapidly in patients with advanced cancer.
TRIAL REGISTRATION NUMBER: NCT05910541.
DESIGN: Retrospective case-control study.
SETTING: Secondary data from the National Tuberculosis Registry (NTBR) across two states in Malaysia.
PARTICIPANTS: All reported DR-TB cases in the NTBR between 2016 and 2020 from Selangor and Wilayah Persekutuan Kuala Lumpur, Malaysia. Cases still undergoing treatment at the time of analysis were excluded. A total of 403 cases were analysed, with 181 (44.9%) experiencing unfavourable treatment outcomes and 222 (55.1%) having favourable treatment outcomes. The case group consists of individuals with DR-TB who experienced unfavourable treatment outcomes, while the control group comprises individuals with DR-TB who achieved favourable treatment outcomes.
OUTCOME MEASURES: Unfavourable treatment outcomes, defined as death, treatment failure or loss to follow-up, were assessed. Predictors of these outcomes were identified through multiple logistic regression analysis.
RESULTS: Significant determinants of unfavourable treatment outcomes included being male (adjusted OR (aOR) 2.38, 95% CI 1.44 to 3.94), being single or divorced (aOR 1.61, 95% CI 1.03 to 2.49), having no formal education (aOR 3.09, 95% CI 1.49 to 6.41), people living with HIV (aOR 2.87, 95% CI 1.40 to 5.87) and having DR-TB categorised as rifampicin-resistant tuberculosis (aOR 3.34, 95% CI 1.90 to 5.86) or multidrug-resistant/pre-extensively drug-resistant/extensively drug-resistant-TB (aOR 2.57, 95% CI 1.52 to 4.33).
CONCLUSION: The findings reveal a high proportion of DR-TB cases with unfavourable treatment outcomes and identify their key determinants. Targeted interventions addressing these factors are essential to improve treatment outcomes.
METHODS: A descriptive and analytic cross sectional study design was conducted from March to September 2021, among antenatal mothers attending routine antenatal follow-ups at 17 public health clinics in Selangor, Malaysia. A validated and reliable self administered questionnaire was used to collect data on demographic characteristics, knowledge, risk perceptions, health self-efficacy, and vaccination intentions among antenatal mothers. Multiple linear regression analysis was used to identify determinants of vaccination intention among antenatal mothers.
RESULTS: The study included 796 antenatal mothers, predominantly Malay mothers (87.5%). The respondents presented a high mean vaccination intention score of 26.02 ± 2.77. Significant determinants of vaccination intention among antenatal mothers included the number of children (β = 0.156, 95% CI [0.013, 0.299], p = 0.032), knowledge score (β = 0.397, 95% CI [0.288, 0.506], p